TriNetX had raised $102m in funding from investors including Merck & Co, Mitsui and Itochu before agreeing to a purchase by Carlyle.
Private equity firm Carlyle Group agreed to acquire US-based clinical research network operator TriNetX for an undisclosed sum on Monday, providing exits for pharmaceutical firm Merck & Co and conglomerates Mitsui and Itochu.
Founded in 2013, TriNetX runs a data-sharing network collating patient records and research data from 170 healthcare organisations such as pharmaceutical firms and research hospitals.
The portal encompasses anonymised and tagged data sourced from more than 400 million patients which can then be used to help identify…
